We provide insights into how cancer‐related DNMT mutations alter de novo methylation in vivo, and demonstrate local and tuneable cytosine methylation by light‐controlled DNMTs fused to a programmable transcription activator‐like effector domain targeting pericentromeric satellite‐3 DNA. The gene discussed is DNMT1; the disease is cancer.